JP Morgan Chase
ACLX

JP Morgan Chase’s Arcellx ACLX Stock Holding History

JP Morgan Chase’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$68.1M Sell
593,573
-860,904
-59% -$76M ﹤0.01% 1193
2025
Q4 		$94.8M Buy
1,454,477
+571,974
+65% +$45.6M 0.01% 968
2025
Q3 		$72.5M Sell
882,503
-94,465
-10% -$6.8M ﹤0.01% 1168
2025
Q2 		$64.3M Buy
976,968
+293,387
+43% +$18.3M ﹤0.01% 1179
2025
Q1 		$44.8M Buy
683,581
+459,125
+205% +$31.1M ﹤0.01% 1368
2024
Q4 		$17.2M Sell
224,456
-25,667
-10% -$2.22M ﹤0.01% 2181
2024
Q3 		$20.9M Sell
250,123
-11,236
-4% -$748K ﹤0.01% 1957
2024
Q2 		$14.4M Sell
261,359
-290,391
-53% -$15.8M ﹤0.01% 2134
2024
Q1 		$38.4M Sell
551,750
-50,163
-8% -$3.18M ﹤0.01% 1444
2023
Q4 		$33.4M Buy
601,913
+38,014
+7% +$1.71M ﹤0.01% 1462
2023
Q3 		$20.2M Buy
563,899
+236,461
+72% +$8.15M ﹤0.01% 1670
2023
Q2 		$10.4M Sell
327,438
-221,759
-40% -$8.48M ﹤0.01% 2263
2023
Q1 		$16.9M Sell
549,197
-194,801
-26% -$5.91M ﹤0.01% 1809
2022
Q4 		$23M Buy
743,998
+590,980
+386% +$13.6M ﹤0.01% 1561
2022
Q3 		$2.87M Buy
153,018
+28,412
+23% +$544K ﹤0.01% 3175
2022
Q2 		$2.25M Buy
124,606
+120,340
+2,821% +$1.55M ﹤0.01% 3442
2022
Q1 		$60K Buy
+4,266
New +$71.3K ﹤0.01% 5719

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase's ACLX Position: Q1 2026 in Review

JP Morgan Chase reduced its Arcellx (ACLX) stake by 59% in Q1 2026, selling an estimated $76M and leaving 593,573 shares worth $68.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1193.

JP Morgan Chase first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. The position peaked at $94.8M in Q4 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • JP Morgan Chase held 593,573 shares of Arcellx worth $68.1M as of Q1 2026.
  • JP Morgan Chase sold 860,904 Arcellx shares in Q1 2026, an estimated $76M.
  • Arcellx made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1193 holding.
  • JP Morgan Chase first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • JP Morgan Chase's Arcellx position peaked at $94.8M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.